Fresh analysis reveals that patients who stop using blockbuster weight-loss injections like Wegovy and Mounjaro may regain lost weight much more quickly than those who stop traditional lifestyle programs.
Findings released in a leading medical journal demonstrates that while obese individuals frequently drop a large proportion of their total mass while undergoing treatment, the weight returns at an estimated rate of nearly a kilo each month upon discontinuation.
"Individuals buying these medications should be cognizant of the danger of fast rebound weight gain when the therapy ends," stated researcher Dr. Susan Jebb.
That rate of recovery implies a reversion to pre-treatment weight within about a year and a half.
Comparing Approaches
The study, which reviewed 37 of studies involving thousands of participants, compared the outcomes of the injectable medications with other pills.
Scientists emphasize that individuals who shed pounds through lifestyle changes alone generally have a slower creep back—perhaps 0.1 kg a month—once they finish.
Understanding the Fast Regain
Doctors suggest the mechanism of the injections accounts for the heightened regain.
These medications copy a natural hormone called GLP-1, which helps regulate feelings of fullness.
"Artificially providing GLP-1 concentrations far above than normal might result in the body to generate a reduced amount of its endogenous hormone, and may also reduce sensitivity to its actions," explained Dr. Adam Collins, a nutrition expert.
"Stopping of this hormone supplement results in hunger is no longer kept in check, making excessive eating far more likely."
A Chronic Issue?
The NHS advise the injections for individuals with obesity-related medical conditions, alongside prescribed diet and exercise modifications.
A number of clinicians say that, due to the likelihood of relapse, the treatment should be considered life-long.
This perspective is echoed by pharmaceutical companies, who state that the findings "highlight the chronic character of obesity," akin to managing conditions like diabetes.
User Testimonies
People who have come off the jabs describe a sudden return of cravings.
"I experienced a trigger activating and I was suddenly starving," described an individual.
The struggle is exacerbated if users have not established permanent lifestyle or habit changes during therapy.
Growing Adoption
Survey data indicate that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with interest continuing to grow.
- Use is more common among women than men.
- The middle-aged age group shows the highest level of interest.
- Many obtain the drugs through private healthcare rather than public health services.
In conclusion, clinicians caution that while the jabs are potent agents for weight loss, they are not a magic cure and long-term success relies on ongoing lifestyle changes.
